[HTML][HTML] Trial of an intervention to improve acute heart failure outcomes

…, P Cram, S Smith, RS McKelvie, L Porepa… - … England Journal of …, 2023 - Mass Medical Soc
Background Patients with acute heart failure are frequently or systematically hospitalized,
often because the risk of adverse events is uncertain and the options for rapid follow-up are …

Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial

…, T Marwick, R McKelvie, G Moe, AS Pandey, L Porepa… - The Lancet, 2022 - thelancet.com
Background Dietary restriction of sodium has been suggested to prevent fluid overload and
adverse outcomes for patients with heart failure. We designed the Study of Dietary …

Newly diagnosed diabetes mellitus as a risk factor for serious liver disease

L Porepa, JG Ray, P Sanchez-Romeu, GL Booth - Cmaj, 2010 - Can Med Assoc
Background: The negative impact of diabetes mellitus is well recognized, yet little is known
about the effect of this disease on the liver, an organ susceptible to nonalcoholic fatty liver …

Effect of patient-centered transitional care services on clinical outcomes in patients hospitalized for heart failure: the PACT-HF randomized clinical trial

…, MC Tjandrawidjaja, M Heffernan, MI Zia, L Porepa… - Jama, 2019 - jamanetwork.com
Importance Health care services that support the hospital-to-home transition can improve
outcomes in patients with heart failure (HF). Objective To test the effectiveness of the Patient-…

Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy

…, P Angaran, Z Laksman, H Zhang, LF Porepa… - Journal of the American …, 2013 - jacc.org
Objectives : The aim of this study was to determine if exercise testing could expose a latent
electrical substrate of arrhythmogenic right ventricular cardiomyopathy (ARVC) in …

Outcomes of heart transplant after left ventricular assist device specific and related infection

…, EG Soltesz, RC Starling, CE Koval, L Porepa… - The Annals of Thoracic …, 2015 - Elsevier
Background Left ventricular assist device (LVAD) infections including drivelines, pump pockets,
and bacteremia are difficult to manage and conservative treatments may not be effective …

Destination therapy with left ventricular assist devices: for whom and when?

LF Porepa, RC Starling - Canadian Journal of Cardiology, 2014 - Elsevier
Historically, cardiac transplantation is the only definitive therapy for mortality reduction,
symptom reduction, and improved quality of life in advanced heart failure. Because of …

Knowledge to action: rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial

…, MI Zia, M Panju, R Perez, KD Simek, L Porepa… - American Heart …, 2018 - Elsevier
Introduction Heart Failure (HF) is a common cause of hospitalization in older adults. The
transition from hospital to home is high-risk, and gaps in transitional care can increase the risk …

Factors impacting physician prognostic accuracy in heart failure patients with reduced left ventricular ejection fraction

…, S Zieroth, K Anderson, C Demers, F Amin, L Porepa… - Heart Failure, 2024 - jacc.org
Background A recent study showed that the accuracy of heart failure (HF) cardiologists and
family doctors to predict mortality in outpatients with HF proved suboptimal, performing less …

Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive …

…, M Toma, S Zieroth, K Anderson, L Porepa… - Circulation: Heart …, 2023 - Am Heart Assoc
BACKGROUND: Many studies have demonstrated that physicians often err in estimating
patient prognosis. No studies have directly compared physician to model predictive …